$336.80
Today
as of Jul 22, 16:50 ET
Last 30 days
Recent Press Releases & News
KRYS: What does Argus have to say about KRYS?
Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600
Krystal Biotech to Join S&P MidCap 400, Replacing Taylor Morrison Home
Overview
52-week range
$128
$319
100% of range
Avg surprise (last 3)
+10.9%
Avg reaction (last 2)
-3.1%
50% positive
Latest IV / EM
53%
EM ±12.1% · $340 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Mon May 4, 2026 | Mar/2026 | $1.83 | $1.45 | +26.2% | +52.5% | +7.9% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $2.66 | — | — | — | — | financials |
| Mon Aug 4, 2025 | Jun/2025 | $1.29 | $1.08 | +19.4% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $1.20 | $1.38 | -13.0% | — | -14.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.91 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.53 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.03 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $2.79 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-1.25 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 3, 2026 | Jun/2026 | OTHER | $1.70 | $1.29 | +31.8% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $116M | — | $98M | $96M | $88M | — | $84M | $70M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $54M | — | $41M | $39M | $36M | — | $22M | $9M |
| Net income | $56M | — | $79M | $38M | $36M | — | $27M | $16M |
| EPS (diluted) | $1.83 | — | $2.66 | $1.29 | $1.20 | — | $0.91 | $0.53 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $501M | $496M | $393M | $354M | $309M | $345M | $374M | $346M |
| Inventory | $43M | $40M | $38M | $31M | $30M | $27M | $19M | $12M |
| Total current assets | $1.02B | $1.02B | $926M | $841M | $767M | $742M | $713M | $683M |
| Total assets | $1.40B | $1.33B | $1.24B | $1.14B | $1.07B | $1.06B | $982M | $918M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $120M | $114M | $102M | $98M | $90M | $109M | $96M | $79M |
| Total equity | $1.28B | $1.22B | $1.14B | $1.04B | $985M | $946M | $886M | $839M |